Subscribe for stories that matter!
Arbutus Biopharma, Warminster, has entered a $300 million licensing and partnership deal with a Chinese biopharmaceutical firm. enters into $300M deal for experimental hepatitis B…
Before we send you to this site, please subscribe to our daily newsletter.